The first-of-its-kind Edwards Lifesciences Sapien M3 TMVR system uses a nitinol dock to anchor the replacement valve in the ...

Edwards Lifesciences Corporation (NYSE: EW) today announced the company’s SAPIEN M3 mitral valve replacement system received CE Mark for the transcatheter treatment of patients with symptomatic ...

These techniques include coronary sinus annuloplasty, direct annuloplasty, leaflet repair strategies and left ventricular chamber remodeling devices. Transcatheter Mitral Valve Repair: Coronary ...

After acquiring its developer last year, Edwards Lifesciences has now obtained a European approval for what it described as ...

The replacement system is launching into markets already served by repair devices, namely Edwards’ Pascal and Abbott’s ...

Edwards Lifesciences announced today that it received CE mark approval for its Sapien M3 mitral valve replacement system.

Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up market rivalry with Abbott. Edwards’ device, dubbed Sapien M3, is the first ...

The Irvine-based medical device maker today announced that it received CE mark approval for its Sapien M3 mitral replacement system.

“We were the first to gain CE Mark for a transcatheter tricuspid valve replacement ... includes both replacement and repair treatment options for both the mitral and tricuspid valves, meeting ...

Edwards SAPIEN M3 mitral valve replacement system receives CE Mark for transcatheter treatment: Irvine, California Wednesday, ...